Skip to main content

and
  1. Article

    Open Access

    Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer’s, and diabetes

    The COVID-19 pandemic caused by the SARS-CoV-2 virus has greatly affected global health. Emerging evidence suggests a complex interplay between Alzheimer’s disease (AD), diabetes (DM), and COVID-19. Given COVI...

    Dicson Sheeja Malar, Kanika Verma, Mani Iyer Prasanth in Scientific Reports (2024)

  2. Article

    Open Access

    The effectiveness of Bacopa monnieri (Linn.) Wettst. as a nootropic, neuroprotective, or antidepressant supplement: analysis of the available clinical data

    Bacopa monnieri (Linn.) Wettst. has been used in traditional medicine as a drug to enhance and improve memory. In this regard, this study aims to provide B. monnieri's efficacy as a neuroprotective drug and as a ...

    James M. Brimson, Sirikalaya Brimson, Mani Iyer Prasanth in Scientific Reports (2021)

  3. No Access

    Article

    Rhizophora mucronata attenuates beta-amyloid induced cognitive dysfunction, oxidative stress and cholinergic deficit in Alzheimer’s disease animal model

    Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, characterized by accumulation and deposition of Aβ peptide in human brain. The present study aimed to determine the protective effect of ca...

    Natarajan Suganthy, Dicson Sheeja Malar, Kasi Pandima Devi in Metabolic Brain Disease (2016)